Replies to post #374265 on Innovation Pharmaceuticals Inc (IPIX)

[zandant]

The concern is that there are always high hopes for this company based on Ehrlich's press releases but the results are ultimately always the same - disappointment. Buck the odds, Leo.

[frenchbroad]

It is not necessary for your hope to be desperate duchamp. Relax and have a good coffee in the morning and wait a wee longer. Work hard and then take a walk.

“It is a rewarding moment for me, as one of the discoverers of Brilacidin, to see Brilacidin continue to receive validation as a promising antiviral treatment—based both on in silico molecular modeling studies and lab research,” commented William F. DeGrado, PhD, Professor in the Department of Pharmaceutical Chemistry at University of California San Francisco (UCSF), and Scientific Advisor for Innovation Pharma. “COVID-19 is, in all likelihood, here to stay. Bringing to market effective coronavirus therapeutics with novel mechanisms less prone to drug resistance developing due to mutations, a characteristic Brilacidin is exhibiting, will be important as the world combats this infectious and deadly virus. I look forward to seeing how Brilacidin performs in its Phase 2 trial in hospitalized COVID-19 patients and am hopeful Brilacidin will emerge as an effective antiviral, with added beneficial immunomodulatory properties.”